Ophthalmology · Santa Clara, CA
NPI
1821069394
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
710 Lawrence Expy, Department 490
Santa Clara, CA, 95051
Phone (408) 851-4062
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$64K
1,325 prescriptions
Company payments, 2025
$4,706
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Huck Holz prescribed most often to Medicare patients was Prednisolone Acetate, with 449 prescriptions and refills. In total Huck Holz wrote 1,325 Medicare prescriptions that cost $64K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisolone Acetate Generic | 449 | 640 | 301 | $39K |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 313 | 314 | 248 | $3,992 |
| Diclofenac Sodium Generic | 271 | 277 | 214 | $5,436 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 61 | 203 | 36 | $1,502 |
| Fluorometholone Generic | 29 | 92 | Under 11 | $4,439 |
| Brimonidine Tartrate Generic | 23 | 46 | 15 | $292 |
| Doxycycline Monohydrate Generic | 19 | 53 | 11 | $692 |
| Moxifloxacin Moxifloxacin Hcl | 19 | 19 | 14 | $183 |
| Ofloxacin Generic | 18 | 18 | 15 | $253 |
| Acetazolamide Er Acetazolamide | 14 | 14 | 11 | $165 |
| Cyclosporine Generic | 11 | 15 | Under 11 | $1,309 |
| Timolol Maleate Generic | 11 | 30 | Under 11 | $166 |
Brand drugs: 482 claims; generic drugs: 843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Huck Holz $4,706 ($4,706 in general payments such as food, travel and fees) from 4 companies. The largest payer was RxSight Inc with $4,500.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.